<DOC>
	<DOC>NCT01862302</DOC>
	<brief_summary>Will the use of prophylactic Haloperidol for patients undergoing open heart surgery reduce the incidence, duration, and severity of post cardiotomy delirium?</brief_summary>
	<brief_title>Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium</brief_title>
	<detailed_description>Pilot study for feasibility and safety, n = 40, haloperidol 1mg vs. placebo BID administered night before and day of surgery, then continued for total 72hrs post-op, if delirium occurs study drug is stopped and usual standard of care implemented by MRP.</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Confusion</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Greater than or equal to 70 years of age, undergoing a median sternotomy OR 6069yrs of age with one or more of the risk factors: TIA/Stroke; Euroscore greater than or equal to 5; abnormal clock draw. Parkinsonism, on any antipsychotic medications preop, active delirium, emergent surgery, Haloperidol allergy, schizophrenia, prolonged QTc.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Prevention delirium</keyword>
	<keyword>Cardiac surgery</keyword>
</DOC>